Introduction {#Sec1}
============

Aflatoxins (AFs) are a group of small molecular weight fungal toxins that threaten world food safety by contaminating \~25% of the world's crops^[@CR1]^. AFs are considered to be an unavoidable contaminant in human food and animal feed by the US Food and Drug Administration (FDA)^[@CR2]^. Among AFs, aflatoxin B1 (AFB1) is the most potent carcinogen present in nature and is produced mainly by the ubiquitous soil filamentous fungus *Aspergillus flavus*^[@CR3]^. AFs are acutely toxic, carcinogenic, mutagenic, teratogenic, and immunosuppressive, and are classified as group 1 carcinogens in human (Fig. [1](#Fig1){ref-type="fig"})^[@CR4]^. Of the 550,000--600,000 new liver cancer cases worldwide each year, it is estimated that 25,200--155,000 may be attributed to AF exposure^[@CR5],[@CR6]^. Due to their high toxicity and carcinogenicity, over 120 countries have set maximum limits of AFs in foods (4\~30 ppb) and feeds (20\~300 ppb)^[@CR1]^. In the U.S. corn industry, AF contamination could cause losses ranging from \$52.1 million to \$1.68 billion annually as was reported in year 2012^[@CR7]^.Figure 1Schematic presentation summarizing the major AFB1 and AFM1 contamination/exposure routes and adverse health effects to human.

AFs can frequently contaminate cereals, oilseeds, spices, tree nuts, corn, groundnuts (peanuts), pistachios, chilies, black pepper, dried fruit and fig, raising global health and economy concerns^[@CR1]^. Furthermore, animal by-products such as milk, meat, and egg can be indirect sources of AF exposure^[@CR8],[@CR9]^. Human milk can have aflatoxin M1 (AFM1), a hydroxylated metabolite of AFB1, and pose a serious threat for infants^[@CR10],[@CR11]^ (Fig. [1](#Fig1){ref-type="fig"}). In certain areas in Africa and Asia, AFs are considered as the leading cause of serious acute illnesses and deaths each year^[@CR12]^. Improper storage of the crops, nuts, and grains further contributes to increased levels of AFs. Unfortunately, over half of the global population is exposed to high, unmonitored levels of AFs^[@CR13]^.

Previous research has demonstrated that both water availability and temperature affect *A*. *flavus* growth and the expression of genes in the AF biosynthesis gene cluster^[@CR14]^. Predictions associated with global warming suggest that *A*. *flavus* is likely to infect more crop plants, and will show increase expression of the AF biosynthetic genes (e.g., *aflD* and *aflR*)^[@CR15]^, enhancing the risk of crop contamination by AF. With a 2 °C temperature increase, AFB1 is predicted to become a food safety issue in the European maize production^[@CR16]^. Several strategies have been developed to reduce AF contamination, including the use of a non-toxigenic strain of *A*. *flavus* to outcompete and displace toxigenic strains^[@CR17],[@CR18]^. This effective biological control method results in greatly reduced AF levels in a diversity of harvested agricultural products and has been applied worldwide^[@CR19],[@CR20]^. Commercially available non-toxigenic *A*. *flavus* isolates include K49 (NRRL 30797, isolated from Maize), Afla-Guard (NRRL 21882, isolated from peanuts), and AF36 (NRRL 18543, isolated from Cottonseed)^[@CR21]^.

Here, we investigated the potential of using *Aspergillus oryzae*, the food grade non-toxigenic domesticated ecotype of *A*. *flavus*, as a biocontrol agent for inhibiting AFB1 production and growth of the toxigenic *A*. *flavus* strain NRRL 3357. *A*. *oryzae* is used for food fermentation (*e*.*g*. sake, miso, soy sauce, meju) and is classified as a Generally Recognized As Safe (GRAS) organism by the FDA and the WHO^[@CR22],[@CR23]^. Fermented soy pastes produced with *A*. *oryzae* are rarely contaminated with AFs. Thus, we hypothesize that there is a strong anti-mycotic potential of *A*. *oryzae* to outcompete *A*. *flavus* in soy-based food. In this study, we have found that *A*. *oryzae* M2040 (designated as M2040 hereafter) isolated from Korean Meju (a soy brick used to make soybean paste called Doen-Jang in Korea) inhibits growth and AFB1 production by *A*. *flavus* significantly better than the widely used commercial biocontrol isolate Afla-Guard. To quantify the competitive effects of M2040, we generated a GFP-labeled *A*. *flavus* NRRL 3357 strain and used to quantify the competitive displacement of *A*. *flavus* by M2040 in peanuts. Importantly, inoculum level of M2040 as low as 1% was effective for controlling of AFB1 production and *A*. *flavus* proliferation. Additionally, cell-free culture filtrate of M2040 grown in potato dextrose broth (PDB) inhibited *A*. *flavus* germination, propagation, and AFB1 production, suggesting the presence of anti-mycotic compound(s) in the M2040 fermentate. Whole genome sequencing and comparative analyses revealed the presence of an additional 1.5 Mbp in the M2040 genome (37.9 Mbp) compared to Afla-Guard (36.4 Mbp). We identified 111 M2040 lineage specific genes arranged in several clusters that may play a role in the observed phenotypes. This report provides a systematic investigation and strong basis for the use of the GRAS fungus *A*. *oryzae* as a potential biocontrol agent for AFB1 contamination in food, and corroborates the expired patent for using certain strains of *A*. *oryzae* and *A*. *sojae* as biocontrol agents (US6027724A).

Results {#Sec2}
=======

Inhibition of AFB1 production by M2040 {#Sec3}
--------------------------------------

To test the central hypothesis that M2040 inhibits AFB1 production, co-culture experiments of M2040 and *A*. *flavus* NRRL 3357, and Afla-Guard and *A*. *flavus* NRRL 3357 in PDB were performed as shown in Fig. [2A](#Fig2){ref-type="fig"}. We tested various media and found that PDB resulted in equal growth rates for M2040 and *A*. *flavus*, and high level production of AFB1. As controls, a set of the 3-day old cultures of M2040 and Afla-Guard were autoclaved (dead) and mixed with the 3-day old culture of *A*. *flavus* NRRL 3357. The mixed cultures were further incubated for up to 12 additional days and the amount of AFB1 was measured every 3 days. As shown in Fig. [2B](#Fig2){ref-type="fig"}, mixing live cells of both M2040 and Afla-Guard with *A*. *flavus* 3357 effectively blocked accumulation of AFB1 throughout the incubation. HPLC chromatograms of AFB1 in 3-day post mixing cultures clearly demonstrate the differences of AFB1 levels between co-culture of *A*. *flavus* 3357 with live and dead M2040 (Fig. [2C](#Fig2){ref-type="fig"}). AFB1 inhibition rates of M2040 were 98.8% and 100% at 3 and 12 days of incubation, respectively. Afla-Guard showed AFB1 inhibition rates of 93.0% and 94% at 3 and 12 days of incubation, respectively. Autoclaved (dead) cells of M2040 and Afla-Guard did not reduce AFB1 accumulation, resulting in accumulation up to 3000 ppb. These data indicate that M2040 can inhibit AFB1 production in PDB when co-cultured.Figure 2Inhibitory effects of *A*. *oryzae* M2040 on AFB1 production by *A*. *flavus*. (**A**) Experimental design. (**B**) Levels of AFB1 accumulation in a liquid co-culture media. \*P \< 0.05; \*\*P \< 0.01. (**C**) HPLC chromatograms of AFB1 at 3-day incubation of *A. flavus* vs dead and live M2040. Note the differences in the AFB1 peak size. (**D**) AFB1 accumulation and in peanut co-inoculated with M2040 and Afla-Guard and *A. flavus* NRRL3357 at different ratios.

To corroborate the control of AFB1 contamination by M2040 on food matrix, we inoculated 1:1, 1:10, and 1:100 ratios of M2040 vs *A*. *flavus* NRRL 3357, and Afla-Guard vs *A*. *flavus* NRRL 3357 on peanuts and examined AFB1 levels at day 5 (Fig. [2D](#Fig2){ref-type="fig"}). At a 1:1 inoculation ratio, both M2040 and Afla-Guard blocked accumulation of AFB1 (Fig. [2D](#Fig2){ref-type="fig"}) compared to *A*. *flavus* NRRL 3357 alone (black bar). Surprisingly however, at 1:10 ratio (10% of a biocontrol strain), M2040 completely inhibited AFB1 accumulation while Afla-Guard allowed AFB1 accumulation to reach \~1,750 ppb. Furthermore, even at 1:100 ratio (1% of biocontrol strain), M2040 led to over 61% inhibition of AFB1 accumulation (Fig. [2D](#Fig2){ref-type="fig"}), whereas Afla-Guard allowed only about 15% inhibition compared to *A*. *flavus* NRRL 3357 alone. Collectively, these data indicate that M2040 has a very strong biocontrol potential that is comparable or superior to Afla-Guard.

Quantification of *A*. *flavus* displacement by M2040 {#Sec4}
-----------------------------------------------------

In the aforementioned experiments AFB1 inhibition experiments, it was impossible to distinguish the target and control strains when they were mixed due to their morphological similarities. Thus, in order to quantify the growth rates of isolates in co-culture, we generated several GFP labeled *A*. *flavus* NRRL 3357 strains by co-transformation, and confirmed that these transformants produced AFB1 similar to wildtype. GFP levels of one strain named AF-GFP is depicted in Fig. [3A,B](#Fig3){ref-type="fig"}.Figure 3Quantitation of *A*. *flavus* displacement by *A*. *oryzae* M2040 and Afla-Guard on peanuts. (**A**) The GFP construct and 5 day old culture of AF-GFP showing highly fluorescent mycelia, hyphae, and conidial suspension. (**B**) Fluorescence (FL) and non-fluorescence images representing inoculation of control groups observed at 5 days of incubation. (**C**) AF-GFP conidial count and AFB1 accumulation in peanut samples co-inoculated with varying ratios of M2040 or Afla-Guard. \*P \< 0.05; \*\*P \< 0.01. (**D**) Fluorescence (FL) and non-fluorescence images of peanuts representing the treatment groups observed at 5 days of incubation. Photographs were taken in a dark room with a 1-2s exposure time.

With the successful generation of AF-GFP, we performed co-inoculation experiments with AF-GFP and M2040, and AF-GFP with Afla-Guard on peanuts with 1:1, 1:10, 1:100, and 1:1,000 ratios. As shown in Fig. [3B--D](#Fig3){ref-type="fig"}, when co-inoculated with AF-GFP at a ratio of 1:1, both M2040 and Afla-Guard completely blocked AFB1 accumulation (100% inhibition rate), and essentially no AF-GFP spores were detected at 5 days of incubation (Fig. [3D](#Fig3){ref-type="fig"}, top panel). Importantly, M2040 exhibited 99% and 65% inhibition rates at 1:10 and 1:100 ratio, respectively, whereas Afla-Guard showed inhibition rates of 60% and 51% at ratio of 1:10 and 1:100, respectively. At 1:1000 ratio, both M2040 and Afla-Guard failed to inhibit AFB1 accumulation. Importantly, the recovery of AF-GFP spores and AFB1 levels were proportional throughout these experiments. At 1:1000 ratio, the peanuts were fully covered by AF-GFP (Fig. [3D](#Fig3){ref-type="fig"}, bottom panel). This experiment resulted in the first quantitative measure for *A*. *flavus* displacement by biocontrol strains, and suggests that M2040 can outcompete a toxigenic *A*. *flavus* strain even when present at only 1%.

Cell-free culture broth of M2040 inhibits AFB1 accumulation {#Sec5}
-----------------------------------------------------------

To test whether M2040 secretes unknown compound(s) into medium that confer AFB1 inhibition, we filter-sterilized (0.45 μm filter) the 8-day old culture of M2040 grown in PDB, and combined the cell-free culture with 3 day old culture of *A*. *flavus* 3357 and 50 ml of fresh PDB (Fig. [4A](#Fig4){ref-type="fig"}). As a control, a set of M2040 PBD culture filtrates were autoclaved (designated as heat-treated) and mixed with the 3 day old *A*. *flavus* culture. Autoclaving abolished the inhibitory effects of the cell-free culture (Fig. [4](#Fig4){ref-type="fig"}). Levels of AFB1 in the mixed medium were determined at 3, 6, 9 and 12 days post mixing. M2040 non-heat-treated culture filtrate was able to inhibit AFB1 accumulation at the inhibition rate of 60--70% compared to the control (heat-treated) group even at 25% levels (25 ml + 75 ml culture and PDB) (Fig. [4B](#Fig4){ref-type="fig"}).Figure 4Effects of cell-free culture filtrate of *A*. *oryzae* M2040. (**A**) Experimental design. (**B**) Time course of the AFB1 accumulation in a mixed liquid of M2040 cell-free culture fermentate and *A. flavus* mycelial cells. \*P \< 0.05. \*\*P \< 0.01. (**C**) Conidial numbers and AFB1 production in HT and non HT M2040 fermentate inoculated with different conidial numbers of *A. flavus*. \*\*P \< 0.05. \*\*P \< 0.01. (**D**) Conidial count and AFB1 production in different concentrations of HT and non HT *A*. *oryzae* fermentate inoculated with 5 × 105 *A. flavus* conidia/ml. \*P \< 0.05. \*\*P \< 0.01. ND: Conidia were not detected under a microscope. Fermentate was diluted in sterile distilled water. (**E**) Conidial count and AFB1 production in different concentrations of HT and non HT M2040 fermentate inoculated with 5 × 10^5^ *A. flavus* conidia/ml. \*\*P \< 0.05. \*\*P \< 0.01. Fermentate was diluted in fresh PDB.

To test the extent of the cell free culture filtrates ability to inhibit propagation and AFB1 production in *A*. *flavus*, we inoculated varying numbers (5 million to 50) of *A*. *flavus* NRRL 3357 spores into 2 mL of 100% culture filtrates, non-heat-treated, and heat-treated groups, and quantified the recovery of *A*. *flavus* spores and AFB1 levels (Fig. [4C](#Fig4){ref-type="fig"}). Non-heat-treated cell-free culture of M2040 effectively inhibited *A*. *flavus* growth and propagation as indicated by low conidial counts compared to the control group. It is important to note that active M2040 culture filtrate could effectively block the growth and AFB1 production even with 500,000 inoculated *A*. *flavus* spores (Fig. [4C](#Fig4){ref-type="fig"}). The maximum dilution levels of M2040 filtrate in water and PDB were further examined for inhibition of 500,000 *A*. *flavus* spores. As shown in Fig. [4D,E](#Fig4){ref-type="fig"}, the non-heat-treated culture fermentate in concentrations of 10%, 25%, 50%, 75%, and 100% (V:V in water or PDB) significantly inhibited *A*. *flavus* NRRL 3357 spore recovery and AFB1 production. These results indicate that the food grade (PDB) culture broth of the GRAS fungus M2040 can be effectively used as a safe agent to control *A*. *flavus* contamination and AF production.

Whole genome sequencing and comparative analyses of M2040 and Afla-Guard {#Sec6}
------------------------------------------------------------------------

In order to verify that M2040 is indeed an *A*. *oryzae* strain lacking the ability to produce AFs, genomic DNA of M2040 was isolated, and genome sequencing was performed as previously described^[@CR24]^. Though a draft genome sequence of Afla-Guard is available^[@CR25]^ we sequenced its genome to obtain sufficient and comparable coverage for our comparative analysis. These genomes were also used to investigate potential genetic differences between *A*. *oryzae* M2040 and *A*. *flavus* Afla-Guard that may underlie their varying ability to inhibit AF production and proliferation of AF producing isolates. The M2040 and Afla-Guard genomes were both sequenced to \>50X coverage and assembled into 1,479 and 1,766 scaffolds, with cumulative assembly sizes of 37.9 and 36.4 Mb, and N50 values of 135.8 Kb and 47.4 Kb, respectively. *In silico* gene prediction yielded 11,782 and 11,489 gene models for the M2040 and Afla-Guard genomes, respectively. Using antiSMASH 3.0, 46 and 42 secondary metabolic gene clusters were predicted in the M2040 and Afla-Guard genomes, respectively.

### Phylogenetic analysis {#Sec7}

The phylogeny of the 17 *A*. *oryzae* and *A*. *flavus* genomes was inferred using 305,543 whole-genome single nucleotide polymorphisms (SNPs: Fig. [5A](#Fig5){ref-type="fig"}). Consistent with earlier work^[@CR26]^, our analysis suggests that the *A*. *oryzae* isolates, including *A*. *oryzae* M2040, are monophyletic and that *A*. *flavus* SRRC 1357 and SRRC 2112 show a closer relationship to *A*. *oryzae* than to other *A*. *flavus* isolates (Fig. [5A](#Fig5){ref-type="fig"}). Our results suggest that *A*. *oryzae* M2040 is extremely closely related to three Japanese sake derived isolates of *A*. *oryzae*, while *A*. *flavus* Afla-Guard is most closely related to *A*. *flavus* SRRC 2632 (Fig. [5A](#Fig5){ref-type="fig"}); a strain capable of producing cyclopiazonic acid, AFB1, and AFB2.Figure 5Comparative genome analyses of *A*. *oryzae* M2040 and Afla-Guard. (**A**) Phylogenetic relationship of *A*. *oryzae* and *A. flavus* isolates. An unrooted phylogeny was generated using the Maximum Likelihood method from 305,543 SNPs across the entire genome. Branch lengths represent the number of substitutions per site. All bootstrap values were ≥94%. Blue and green taxa labels represent *A*. *oryzae* and *A. flavus*, respectively. (**B**) Deletion profiles in the AF gene cluster. The chromosomal architecture of the AFB1 gene cluster relative to the *A. flavus* NRRL 3357 genome is shown above the heatmap, where arrows represent genes, and their orientations represents the direction of transcription. The heatmap represents copy number estimates for each non overlapping 100 bp bin across the AF gene cluster. Black and white represent copy numbers of 0 and ≥1, respectively. Bottom bar shows the Afla-Guard heatmap depicting deletions relative to the AF gene cluster containing *A. flavus* NRRL 3357 EQ963478 scaffold. Windows represent copy number estimates for each non-overlapping 10 kb bin across the scaffold. The chromosomal region containing the AF cluster is outlined with a red box. (**C**) Genome architecture of examples M2040 lineage specific genes clusters. Microsynteny of regions covering a three gene (top) and 17 gene (bottom) cluster unique to the M2040 genome in comparison to *A*. *oryzae* RIB 40, *A. flavus* NRRL 3357 and Afla-Guard. For each cluster arrows represent genes, and their orientations represents the direction of transcription. Genes colored black are conserved in at least 2 isolates, while genes colored light blue are unique to the M2040 genome. Gray blocks represent genomic regions exhibiting sequence similarity between isolates. Chromosome, or scaffold identifiers containing these loci are listed under each isolate. Gene identifiers are listed for each gene in panel A, and for the range of genes in panel.

### AF gene cluster variation {#Sec8}

Using a read depth approach, we estimated copy number for each non-overlapping 100 bp bin across the AF biosynthetic gene cluster. *A*. *oryzae* M2040 possesses a number of deletions, including the intergenic region between the divergently transcribed *norB* and *cypA* genes^[@CR27]^. *norB* is an aryl alcohol dehydrogenase, and *cypA* is a cytochrome P450 monooxygenase^[@CR28]^. Both genes are involved in aflatoxin G formation. Isolates with this deletion do not express *norB* or *cypA*^[@CR26]^. The entire AF biosynthetic gene cluster is deleted in *A*. *flavus* Afla-Guard (Fig. [5B](#Fig5){ref-type="fig"}). Closer examination of the *A*. *flavus* Afla-Guard genome reveals a \~155 Kb deletion beginning at the AF gene cluster and extending to the end of the chromosome (Fig. [5C](#Fig5){ref-type="fig"}).

### Identification of *A*. *oryzae* M2040 lineage specific genes {#Sec9}

Using a conservative BLAST based approach, lineage specific genes were identified in *A*. *oryzae* RIB 40, *A*. *oryzae* M2040, *A*. *flavus* NRRL 3357, and *A*. *flavus* Afla-Guard, with special focus given to *A*. *oryzae* M2040. We identified 111, 58, 140, and 111 lineage specific genes in the *A*. *oryzae* M2040, *A*. *oryzae* RIB 40, *A*. *flavus* NRRL 3357, and *A*. *flavus* Afla-Guard genomes, respectively. PFAM domains were predicted for 55 of the 111 *A*. *oryzae* M2040 genes. Interestingly, we identified two genes encoding proteins with heterokaryon incompatibility domains, one gene encoding a protein with an aminoglycoside phosphotransferase domain which confers resistance to various aminoglycosides, as well as several other genes encoding transporters, transcription factors, and protein kinases (Table [1](#Tab1){ref-type="table"}).Table 1PFAM and InterPro annotation for *A*. *oryzae* M2040 lineage specific genes. The *A*. *oryzae* M2040 lineage specific genes and predicted domains.ScaffoldGene IDPFAM DomainInterPro ClassificationNODE_14g1437Carbon-nitrogen hydrolaseCarbon-nitrogen hydrolaseNODE_17g1677Domain of unknown function (DUF3328)Mycotoxin biosynthesis protein UstYa-likeNODE_17g1678Domain of unknown function (DUF3328) (x2)Mycotoxin biosynthesis protein UstYa-like (x2)NODE_35g3027Ankyrin repeat (x2)Ankyrin repeat (x2)Ankyrin repeats (many copies)AAA + ATPase domainAAA domainAnkyrin repeat-containing domainAnkyrin repeats (3 copies)NODE_54g4145Phosphotransferase enzyme familyAminoglycoside phosphotransferaseNODE_54g4153Patatin-like phospholipasePatatin-like phospholipase domainNODE_54g4155FAD-binding domainFAD-binding 8Ferric reductase NAD binding domainFerric reductase, NAD binding domainNODE_54g4156Protein kinase domainProtein kinase domainNODE_54g4157Protein of unknown function (DUF3723)Protein of unknown function DUF3723NODE_54g4161Protein of unknown function (DUF3435)Protein of unknown function DUF3435NODE_73g5191WD domain, G-beta repeat (x8)WD40 repeat (x8)NODE_193g9143SET domainSET domainNODE_194g9174AAA domain (x2)NODE_194g9176Argonaute linker 1 domainPiwi domainPiwi domainArgonaute, linker 1 domainPAZ domainPAZ domainHelicase conserved C-terminal domainHelicase, C-terminalN-terminal domain of argonauteProtein argonaute, N-terminalDicer dimerisation domainDicer dimerisation domainRibonuclease III domain (x2)Ribonuclease III domain (x2)NODE_289g10541Protein kinase domainProtein kinase domainUlp1 protease family, C-terminal catalytic domainUlp1 protease family, C-terminal catalytic domainNODE_290g10546Man1-Src1p-C-terminal domainMan1-Src1p-C-terminal domainNODE_326g10914Ferric reductase like transmembrane componentFerric reductase transmembrane component-like domainFAD-binding domainFAD-binding 8NODE_326g10915Phosphorylase superfamilyNucleoside phosphorylase domainNODE_326g10916Protein kinase domainProtein kinase domainNODE_341g11019Protein of unknown function (DUF3645)Protein of unknown function DUF3645Protein of unknown function (DUF3638)Protein of unknown function DUF3638NODE_369g11222Heterokaryon incompatibility protein (HET)Heterokaryon incompatibilityNODE_371g11231Shwachman-Bodian-Diamond syndrome (SBDS) proteinRibosome maturation protein SBDS, N-terminalATP synthase alpha/beta chain, C terminal domainATP synthase, alpha subunit, C-terminalATP synthase alpha/beta family, beta-barrel domainATPase, F1/V1/A1 complex, alpha/beta subunit, N-terminal domainATP synthase alpha/beta family, nucleotide-binding domainATPase, F1/V1/A1 complex, alpha/beta subunit, nucleotide-binding domainNODE_371g11232V-type ATPase 116 kDa subunit familyV-type ATPase, V0 complex, 116 kDa subunit familyNODE_378g11269Man1-Src1p-C-terminal domainMan1-Src1p-C-terminal domainNODE_378g11273Methyltransferase domainMethyltransferase type 11NODE_384g11303Heterokaryon incompatibility protein (HET)Heterokaryon incompatibilityNODE_404g11391ATPase family associated with various cellular activities (AAA)ATPase, AAA-type, coreNODE_416g11434Glycosyl hydrolase family 10 (x2)Glycoside hydrolase family 10 domain (x2)NODE_417g11436Glycosyl hydrolases family 32 N-terminal domainGlycosyl hydrolase family 32, N-terminalNODE_417g11437Sugar (and other) transporterMajor facilitator, sugar transporter-likeNODE_437g11494Alcohol dehydrogenase GroES-like domainAlcohol dehydrogenase, N-terminalZinc-binding dehydrogenaseAlcohol dehydrogenase, C-terminalNODE_437g11495Eukaryotic elongation factor 5 A hypusine, DNA-binding OB foldTranslation elongation factor, IF5A C-terminalElongation factor P (EF-P) KOW-like domainTranslation elongation factor, KOW-likeNODE_450g11526Cation transporter/ATPase, N-terminusCation-transporting P-type ATPase, N-terminalNODE_450g11527MAC/Perforin domainMembrane attack complex component/perforin (MACPF) domainNODE_454g11536Ankyrin repeats (3 copies) (x3)Ankyrin repeat-containing domain (x3)Ankyrin repeats (many copies)Fungal specific transcription factor domainTranscription factor domain, fungiAAA domainAAA + ATPase domainNODE_468g11564Protein of unknown function (DUF3435)Protein of unknown function DUF3435NODE_468g11565Protein kinase domainProtein kinase domainNODE_472g11572Protein of unknown function (DUF3435)Protein of unknown function DUF3435NODE_476g11576NmrA-like familyNmrA-like domainNODE_479g11582Glycosyltransferase family 25 (LPS biosynthesis protein)Glycosyl transferase, family 25NODE_479g11583Glycosyltransferase sugar-binding region containing DXD motifGlycosyltransferase, DXD sugar-binding motifNODE_486g11594Ankyrin repeats (3 copies) (x2)Ankyrin repeat-containing domain (x2)NODE_486g11595Glycosyl transferase family 8Glycosyl transferase, family 8NODE_494g11605Phosphotransferase enzyme familyAminoglycoside phosphotransferaseNODE_498g11612NACHT domainNODE_501g11617Clostridium epsilon toxin ETX/Bacillus mosquitocidal toxin MTX2Clostridium epsilon toxin ETX/Bacillus mosquitocidal toxin MTX2NODE_513g11632Haloacid dehalogenase-like hydrolaseCation transporting ATPase, C-terminusCation-transporting P-type ATPase, C-terminalNODE_541g11662T5orf172 domainBacteriophage T5, Orf172 DNA-bindingNODE_573g11683LysM domain (x3)LysM domain (x3)NODE_578g11688Sodium/hydrogen exchanger familyCation/H+ exchangerNODE_612g11709Sugar (and other) transporterMajor facilitator, sugar transporter-likeNODE_654g11732Phosphorylase superfamilyNucleoside phosphorylase domainNODE_691g11743Peptidase family M49NODE_713g11751BTB/POZ domainBTB/POZ domainNODE_860g11779E1-E2 ATPaseGenes containing 2, 3, and 8 identical PFAM or InterPro domain are denoted as x2, x3, and x8, respectively. Genes g1679, g4146, g4147, g4148, g4149, g4150, g4151, g4152, g4154, g4158, g4159, g4160, g9173, g9175, g9177, g10449, g10540, g10542, g10543, g10544, g10545, g10547, g10913, g10943, g10944, g10945, g10946, g10947, g11018, g11020, g11270, g11271, g11272, g11307, g11438, g11487, g11503, g11504, g11566, g11588, g11660, g11673, g11674, g11681, g11682, g11699, g11707, g11714, g11716, g11729, g11733, g11736, g11760, g11765, g11777, and g11780 contained no predicted PFAM or InterPro classification.

In *A*. *oryzae* M2040, 63% of lineage specific genes were found in clusters of two or more genes, with an average cluster size of \~4 genes and the largest cluster containing 17 genes. Of note, we identified a cluster of three lineage specific genes in *A*. *oryzae* M2040 in which two of the genes contain mycotoxin biosynthesis protein UstYa-like domains (Fig. [5C](#Fig5){ref-type="fig"}). This protein domain is involved in the production of toxic cyclic peptides. Additionally, we identified a 17 gene cluster with varying genome architecture between *A*. *oryzae* M2040, *A*. *oryzae* RIB 40, and the two *A*. *flavus* isolates (Fig. [5C](#Fig5){ref-type="fig"}). Most of these genes encode proteins annotated as hypothetical proteins in other organisms, though BLAST searches against the RefSeq non-redundant protein database, PFAM domain prediction, and InterPro classification revealed proteins annotated as phosphotransferase family protein, patatin/phospholipase A2-related, tyrosine-protein kinase, and casein kinase family protein.

Discussion {#Sec10}
==========

The use of atoxigenic *A*. *flavus* to control AFs was demonstrated in 1990s (Peter Cotty USDA Agricultural Research Service) in Arizonian cotton fields^[@CR18]^. However, studies dated back to 1965 found that AF levels can be reduced by co-cultivating toxigenic *A*. *flavus* strains with certain fungi or bacteria^[@CR29],[@CR30]^. This biocontrol strategy is currently the most widely used method for reducing contamination levels of AFs in some crops. Nevertheless, there are many challenges facing this strategy at both short and long-term^[@CR31],[@CR32]^. One of the major drawbacks of the biocontrol strategy is a potential risk of introducing a heavy dose of *A*. *flavus* strains that could alter the soil microbiome populations especially with global warming. The inherent diversity of *A*. *flavus* populations makes a biocontrol strategy more difficult because *A*. *flavus* populations differ in their abilities to produce AFs and other toxic secondary metabolites^[@CR31]^. To address these potential issues, we tested the potential use of *A*. *oryzae* M2040 as a biocontrol agent.

Prior to the beginning of the studies, we tested the inhibitory activity of 10 *A*. *oryzae* strains and found that M2040 most significantly inhibited AF production and *A*. *flavus* growth. Our data indicates that AFB1 is not detected in PDB when equal number of spores of *A*. *oryzae* and *A*. *flavus* are co-inoculated. Therefore, in order to test the precise inhibitory effects, we cultured each strain separately for 3 days and mixed equal volume (25 mL each) of the fungal cell aggregates (mycelia) in new PDB medium (50 mL) and quantified submerged growth and AFB1 production. Additionally, Afla-Gurad^®^ was selected as a positive control based on its effective use *in vitro* and in the field to control AFs contamination. Both live cells of *A*. *oryzae* and Afla-Gurad^®^ significantly inhibited AFB1 accumulation over a range of laboratory conditions indicating that fungal cell-cell interactions may act as an additional control factor mediating the inhibitory process.

To track the competitive effect of nontoxigenic strains, we co-inoculated M2040 and Afla-Guard at varying inoculum levels with a transgenic *A*. *flavus* NRRL 3357 (AF-GFP) strain expressing GFP on peanut samples. AFB1 was measured as well. Previous experiments indicated that Afla-Guard can result in more than 85% reduction in AFs^[@CR33],[@CR34]^. At 1:1 ratio, the AF-GFP fluorescence in the co-inoculated peanut kernels was significantly reduced, and AFB1 was not detected by when co-cultured with M2040 or Afla-Guard. Since the inoculum size is the same for both non-toxigenic and toxigenic strains, the faster growing isolate (biocontrol strains) should outcompete the other isolate (toxin-producing strain). However, when both biocontrol agents were further diluted to 10% levels, M2040 clearly showed superior reduction (87%) in total AFB1 accumulation compared to Afla-Guard (60.6%). Abbas *et al*.^[@CR21]^ reported 58% and 83% in AF reduction when they applied the non-aflatoxigenic *A*. *flavus* K49 strain in the two-corn fields at a ratio of 10-fold dilution. However, when K49 was applied at equal inoculum size with toxigenic one, AFs were reduced by 86% and 96%. It has been hypothesized that displacement of the toxigenic strains occurs simply by the biocontrol strains superior ability to better sequester nutrients. However, using different biocontrol strains has resulted in variable reduction rates of AFs, suggesting that other unknown factors may be involved for the biocontrol mechanism such as the production of extracellular compounds that might inhibit AFB1 production. M2040 showed significant activity for AFB1 reduction (50%) even at 100-fold dilution compared to Afla-Guard (26%), however, at 1000-fold dilution, both biocontrol agents resulted in AFB1 reduction of less than 10%.

When cell free culture fermentate of M24040 was tested for inhibiting the mycelial growth and AFB1 production of *A*. *flavus*, it was found to be highly effective against AFB1 production by reducing levels by more than 70%. Furthermore, our broth microdilution experiments revealed that the fermentate was found to be highly effective in inhibiting conidial germination and AFB1 production. The inhibitory activity of the culture fermentate was observable even at 10% concentration and these effects were abolished by autoclaving, but not by treating with proteinase K. These results suggest the non-protein nature of the active substances in the fermentate.

To better understand the phenotypic differences between M2040 and Afla-Guard through a broader evolutionary context, we sequenced the genomes of both isolates. This analysis yielded several key findings. First, we note that Afla-Guard is nested within an aflatoxigenic clade of *A*. *flavus*, and most closely related to the clinical isolate *A*. *flavus* SRRC 2632 which is capable of producing AF and cyclopiazonic acid (CPA) (Fig. [5A](#Fig5){ref-type="fig"}). Our read depth analysis confirms that the Afla-Guard genome lacks the ability to produce AF and CPA because of a \~155 Kb deletion spanning the gene clusters encoding both of these secondary metabolites^[@CR35]^ (Fig. [5B](#Fig5){ref-type="fig"}). Additionally, our phylogenetic analysis revealed that M2040 is nearly identical to three Japanese strains isolated from miso (RIB 331 and RIB 333) and sake (642) (Fig. [5A](#Fig5){ref-type="fig"}).

Genome sequencing of M2040 and Afla-Guard also allowed us to conduct comparative genomic analysis to identify potential gain-of-function genes that might be associated with the inhibitory ability of M2040. We hypothesized that certain genes involved in unknown anti-fungal products may curtail growth and AF production of *A*. *flavus*. We identified 111 lineage-specific genes in the M2040 genome, including several genes that may be involved in biosynthesis of toxin-like products. For instance, gene *g11617* was annotated by a "Clostridium epsilon toxin ETX/Bacillus mosquitocidal toxin MTX2" domain (Table [1](#Tab1){ref-type="table"}). BLAST searches against the NCBI non-redundant protein database reveal the presence of this gene in the *A*. *oryzae* BCC7051 genome^[@CR36]^, along with only two other significant hits to the *Talaromyces cellulolyticus* Y-94 genome^[@CR37]^ (E-value = 7e^−17^) and the *Botrytis cinerea* BcDW1 (E-value = 8e^−12^)^[@CR38]^. We also identified two neighboring genes (*g1677* and *g1678*) that have the Interpro classification "Mycotoxin biosynthesis protein UstYa-like" (Fig. [5C](#Fig5){ref-type="fig"}). *ustYa* is an oxidase involved in the production of ustiloxins and homologs have been identified in *A*. *flavus* NRRL 3357^[@CR39]^ and *A*. *oryzae* RIB 40. However, homologs to the *A*. *oryzae* M2040 genes *g1677* and *g1678* are not present in *A*. *oryzae* RIB 40, *A*. *flavus* NRRL 3357, or *A*. *flavus* Afla-Guard, and BLAST searches against the NCBI non-redundant protein database show a patchy distribution across Ascomycota including *A*. *oryzae* BCC7051^[@CR36]^, *A*. *bombycis*^[@CR40]^, *A*. *udagawae*^[@CR41]^, *Xylona heveae*^[@CR42]^, *Penicillium oxalicum*^[@CR43]^, and *Penicillium nordicum*^[@CR44]^. Moving forward, defining the transcriptional landscape of M2040 in co-culture will allow us to further narrow in on the genes involved in inhibiting AF production and growth.

In conclusion, our studies raise the idea of potentially using a food grade *A*. *oryzae* strain as a potent biocontrol agent to reduce *A*. *flavus* growth and AF contamination. Additionally, *A*. *oryzae* cell free PDB fermentate could be employed as a valuable biocontrol agent. To the best of our knowledge, our report is the first study systematically showing the advantages of using GRAS fungus, and its fermentate to control *A*. *flavus* growth and AFs contamination. These results, along with further studies, will eventually provide a GRAS product(s) that can be used as a natural anti-fungal and anti-AF agent.

Materials and Methods {#Sec11}
=====================

Fungal strains and culture conditions {#Sec12}
-------------------------------------

The aflatoxigenic strain *A*. *flavus* NRRL3357 was used as a high AFB1 producer^[@CR45]^. *A*. *flavus* NRRL3357 labeled with green fluorescent protein (AF-GFP) was developed and used in this study. Bright fluorescence was observed for mycelia and hyphae of the AF-GFP (Fig. [3A](#Fig3){ref-type="fig"}). *A*. *flavus* NRRL 21882 (Afla-Guard) and *A*. *oryzae* M2040 (isolated from Meju, Korea) were used as non-aflatoxigenic strains. All strains were maintained on potato dextrose agar (PDA) medium (containing 4 g potato starch, 20 g glucose, and 15 g agar in 1 L of distilled water) at 4 °C. To prepare inoculum, *Aspergillus* cultures were grown on PDA for 7 days at 30 ± 2 °C. Spores were harvested from individual cultures on PDA using 0.1% Tween-80 solution. Asexual spores (conidia) were counted with a hemocytometer and numbers were adjusted to 5 × 10^7^ conidia/mL with water. Fungal spore suspensions were stored at 4 °C and used within 1 week of preparation.

Generation of GFP labeled *A*. *flavus* NRRL 3357 strains {#Sec13}
---------------------------------------------------------

The oligonucleotides used in this study are listed in Table [2](#Tab2){ref-type="table"}. Double joint PCR (DJ-PCR) was used to generate AF-GFP strains^[@CR46]^. To generate the PCR amplicon of the GFP Open Reading Frame (ORF), the primer pair OMK751; OMK752 was used from pFNO3 (vectors provided by Dr. P. N Keller) plasmid DNA. Both 5′ and 3′ flanking regions of the glyceraldehyde phosphate dehydrogenase (*gpdA*) gene was amplified from genomic DNA of *A*. *flavus* NRRL 3357 using OMK740; OMK754 and OMK755; OMK741. The final DJ-PCR of AF-GFP construct was amplified with OMK742; OMK743. The *A*. *flavus pyrG*^+^ marker was amplified with the primer pair OMK639; OMK640. The final DJ-PCR construct and the *A*. *flavus pyrG*^+^ marker amplicons were co-introduced into *A*. *flavus* NRRL3357.5 (*pyrG*^-^). Protoplasts were generated using the Vinoflow FCE lysing enzyme as described (Novozymes)^[@CR47]^. Fungal transformants were isolated and confirmed by PCR followed by restriction enzyme digestion^[@CR46]^. At least three independent AF-GFP strains were isolated and confirmed for AFB1 production.Table 2Oligonucleotides used in this study.NameSequence (5′ → 3′)PurposeOMK740TCACTGAAAAAGAGCTAAGACTA5′ flanking of AFL *gpdA*OMK741TCCCATGACAGTGTCTTCGT3′ flanking of AFL *gpdA*OMK742ACCCCAGTACAGTTTCATGCAA5′ nest of AFL *gpdA*OMK743TTGCGCAGAAGCCTAGACAAGTC3′ nest of AFL *gpdA*OMK751ATGAGTAAAGGAGAAGAACTT5′ GFP ORFOMK752TTTGTATAGTTCATCCATGC3′ GFP ORFOMK754*AAGTTCTTCTCCTTTACTCAT*TGTTTAGATGTGTCTGTTG3′ AFL *gpdA* with GFP tail^a^OMK755*TGGCATGGATGA ACTATACAAA*AAGTCATACCTAACAAGTGCT5′ AFL *gpdA* with GFP tail^a^OMK639TCGAGAGATGAGGGCTGCCAGCA5′ *AFL pyrG* markerOMK640CAGAAGAAAAGGATGATCAATAC3′ *AFL pyrG* marker^a^Tail sequence is in italic.

Reagents and chemicals {#Sec14}
----------------------

AFB1 standard was purchased from Sigma-Aldrich (U.S.). Water, methanol, acetonitrile chloroform were purchased from Fisher Chemical (U.S.). All solvents were of HPLC-grade. Membrane filters (47 mm × 0.45 μm) and syringe filters (13 mm × 0.2 μm) were obtained from Millipore (U.S.).

HPLC analysis of AFB1 {#Sec15}
---------------------

### Extraction of AFB1 from liquid culture media {#Sec16}

AFB1 was extracted from submerged media by liquid-liquid extraction. Briefly, 2 ml of the fungal culture broth was mixed with equal volume of chloroform in 15-ml centrifuge tube and vortexed for 60 sec, left at room temperature for 5 min, then vortexed again for 60 sec. The mixture was then centrifuged for 5 min at 5000 *g*. Two ml of the lower layer was transferred to a new glass vial. The chloroform extracts were evaporated to complete dryness under a gentle stream of air. The dried extracts were reconstituted with 1 ml methanol. All samples were filtered into HPLC vials through 0.2 μm syringe filter prior to HPLC analysis.

### Measurement of conidia and AFB1 from peanut {#Sec17}

Extraction of AFB1 from peanuts was performed as described^[@CR48]^ with slight modifications. Two peanut cotyledons were placed in a 50-ml Falcon tube containing 5 ml of 0.1% Tween 80 and each tube was vortexed thoroughly. To check the conidial number, 1 mL was transferred from each sample into an Eppendorf tube and spores were counted. Next, 5 mL of acetone was added to the remaining samples, followed by shaking for 15 min in a rotary shaker at 150 rpm. Samples were kept standing for 5 min at room temperature, 5 ml of chloroform was then added, and samples were agitated for 15 min at 150 rpm. Samples were left to stand for an additional 5 min at room temperature. The organic lower layer was collected by centrifugation of samples for 10 min at 5000 *g*, transferred to a new tube and dried under gentle stream of air. The dried extracts were reconstituted with 1 ml methanol. All samples were filtered into HPLC vials through 0.22 μm disposable syringe filter prior to HPLC analysis.

### Chromatographic conditions {#Sec18}

Samples were analyzed for AFB1 using a model 1100 HPLC system consisting of a degasser, an autosampler, a quaternary pump, and a diode array (DAD) detector (Agilent). Samples were eluted at a wave length of 365 nm with a mobile phase of H~2~O:CH~3~OH:CH~3~CN (50:40:10) at a flow rate of 0.8 ml/min. The mobile was degassed and filtered through membrane filter (47 mm × 0.45 μm) prior to use. The separation was performed *via* a Zorbax Eclipse XDB-C18 4.6 mm × 150 mm, 3.5 μm column. The injection volume was 10 μl. AFB1 peaks area were recorded and integrated using ChemStation software (Agilent). The limit of AFB1 detection was 1 ppb.

Determining the effect of *A*. *oryzae* M2040 on AFB1 production in submerged culture {#Sec19}
-------------------------------------------------------------------------------------

Conidia (5 × 10^7^) of *A*. *oryzae* M2040 and *A*. *flavus* NRRL 3357 were separately inoculated into PDB (100 ml) in 250 ml Erlenmeyer flask and incubated at 30 ± 2 °C with shaking at 220 rpm. After 3 days, 25 ml of *A*. *oryzae* and 25 ml of *A*. *flavus* mycelia were transferred to a new 250 ml Erlenmeyer flask containing 50 ml of fresh PDB. This co-cultured mixture (100 ml) was incubated for 12 days under the same culture conditions mentioned above. AFB1 concentration in the culture medium was assayed every three days. The following three controls were used in this study; 1) Co-cultured mixture of *A*. *flavus* and dead cells of *A*. *oryzae* M2040 heat-treated by autoclaving at 121 °C and 15 psi for 20 min, 2) *A*. *flavus* NRRL 3357 only, 3) Co-cultured mixture of *A*. *flavus* NRRL 3357 and *A*. *flavus* Afla-Guard. All treatments were tested in triplicate flasks and the experiment was performed three time.

Determining the effect of *A*. *oryzae* M2040 on *A*. *flavus* growth and AFB1 production in peanuts {#Sec20}
----------------------------------------------------------------------------------------------------

We tested the effect of varying inoculation ratios of *A*. *oryzae* M2040, *A*. *flavus* Afla-Guard, and our toxigenic GFP-labeled strain of *A*. *flavus* NRRL 3357 (AF-GFP) on AFB1 accumulation and sporulation 5 days after inoculation. This experiment was performed in triplicate for each treatment group and repeated twice.

### Preparation of peanut samples {#Sec21}

Peanut infection procedure was performed as described previously^[@CR49]^ with some modifications. Mature peanut seeds were obtained by local market and prepared by removing the exterior layer. Two cotyledons were separated, and the embryo was removed gently. Then, cotyledons (0.5 g) were surface sterilized by placing them in beaker containing 0.05% NaClO in sterile water for 2 min. Then the cotyledons were washed by placing them in a new beaker containing sterile distilled water for 1 min, followed by a 10-second wash with 70% ethanol in a new beaker. A final washing step with sterile distilled water for 2 min was performed to ensure complete removal of detergents. The cotyledons were dried completely for at least 2 hours under aseptic condition until the time of infection.

### Peanut infection {#Sec22}

Peanut cotyledons were allocated into four treatment groups. Group 1 was inoculated with 100,000 spores of AF-GFP alone, which served as a control. Group 2 was co-inoculated with 1:1 (10^5^:10^5^), 1:10 (10^4^:10^5^), 1:100 (10^3^:10^5^), and 1:1000 (10^2^:10^5^) of *A*. *oryzae* M2040 relative to 10^5^ spores of AF-GFP. Group 3 was inoculated with 1:1 (10^5^:10^5^), 1:10 (10^4^:10^5^), 1:100 (10^3^:10^5^), and 1:1000 (10^2^:10^5^) of *A*. *flavus* Afla-Guard relative to 10^5^ spores of AF-GFP. Group 4 was treated with water (mock inoculation). For all treatments, 10 peanut cotyledons were used for each plate in triplicate. Cotyledons were placed in petri dishes lined with 3 pieces of moist filter paper and a water reservoir (lid of a 50 ml centrifuge tube containing 2 ml of sterile water) to maintain high humidity. Cotyledons were incubated for 5 days at 30 °C.

### Determination of conidia number and AFB1 accumulation {#Sec23}

AFB1 was extracted from peanut cotyledons as described above and calculated for all treatment groups. In order to determine the extent of AF-GFP growth in peanut and the percentage of toxigenic strain reduction, conidia of AF-GFP were counted in all groups by hemocytometer and the microscopy images were taken using a Zeiss Axio Observer D4 Fluorescence Microscope with Achromat S 1, 5x FWD 28 mm lenses (Carl Zeiss, Germany).

Determining the effects of cell free culture fermentate of *A. oryzae* M2040 on *A*. *flavus* growth and AFB1 production {#Sec24}
------------------------------------------------------------------------------------------------------------------------

The effects of cell free culture fermentate on AFB1 production by *A*. *flavus* was studied in 250 ml Erlenmeyer flasks under submerged culture condition. Conidia (5 × 10^7^) of *A*. *oryzae* and *A*. *flavus* were inoculated separately in 100 ml PDB and incubated at 30 ± 2 °C with shaking at 220 rpm. After 3 days, 25 ml of *A*. *oryzae* M2040 cell free culture fermentate was transferred to a new flask containing 50 ml of fresh PDB and, at this time, 25 ml of *A*. *flavus* mycelia was also added to this flask. This mixture was incubated for 12 days under the same culture conditions mentioned above and the AFB1 concentrations in the culture medium were assayed every 3 days of incubation. Autoclaved (heat-treated) cell free culture fermentate was used as a control. All treatments were tested in triplicate and the experiment was repeated twice.

### Production of the cell free culture fermentate {#Sec25}

Conidia (5 × 10^8^) of *A*. *oryzae* M2040 were inoculated into 1000 mL of PDB in a 2 L Erlenmeyer flasks and incubated at 30 ± 2 °C for 8 days with shaking at 220 rpm. The mycelia were separated from the culture broth by filtration with four layers of Miracloth (MilliporeSigma) and the cell free culture fermentate was obtained by filtering through a 0.2 μm PES filter unit (Thermo Scientific, USA). The fermentate was kept at 4 °C and used within one month of production. Portions of the fermentate were treated with proteinase-K (BDH Biochemicals).

### Testing the effect of cell-free culture fermentate on the growth and germination of A. flavus at different conidia counts {#Sec26}

Using a 24-well microdilution plate, 2 ml of the fermentate was loaded into 6 wells and *A*. *flavus* conidia were kept in the first well at 5 × 10^6^ conidia/ml final concentration. Ten-fold serial dilutions were made to 5 × 10^1^ conidia/ml. Heat treated fermentate served as a control. The plate was incubated at 30 ± 2 °C for 5 days. Samples were harvested, conidia counted with a hemocytometer, and AFB1 levels were estimated. All treatments were tested in triplicate wells and repeated at least three times.

### Testing different concentrations of cell-free culture fermentate on the growth and germination of A. flavus {#Sec27}

Cell-free culture fermentate was diluted in sterile distilled water or PDB to give final concentration (v/v) of 100%, 90%, 75%, 50%, 25%, and 10%. Heat-treated cell-free culture fermentate was prepared as a control. Two ml of treatment groups were loaded into the well and *A*. *flavus* was inoculated in all wells at a final concertation of 5 × 10^5^ conidia/ml. The plate was incubated at 30 ± 2 °C for 5 days. Samples were harvested, conidia were counted with a hemocytometer, and AFB1 levels were quantified. All treatments were tested in triplicate wells and repeated at least three times.

Genome Sequencing and Assembly of *A. oryzae* M2040 and Afla-Guard {#Sec28}
------------------------------------------------------------------

Genomic DNA was extracted as previously described^[@CR24]^. A paired-end 152-bp Illumina library was constructed from genomic DNA and sequenced at ProteinCT (Madison, Wisconsin). Illumina sequence data were first deduplicated using Tally^[@CR50]^. Next, trim_galore (<https://www.bioinformatics.babraham.ac.uk/projects/trim_galore/>) was used to trim reads at bases with quality scores \< 30. Trimmed read pairs, with at least 1 read \< 50 bp were discarded. Trim_galore was also used to removed residual adapter sequences from reads, using the conservative parameter "stringency = 1". Lastly, this set of deduplicated, quality trimmed, and adapter trimmed reads were error corrected using SPAdes version 3.10.0^[@CR51]^, resulting in a high-quality dataset of 15,376,723 paired-end reads, representing \~115X coverage for M2040, and 8,042,928 paired-end reads, representing \~53X coverage for Afla-Guard. Both genomes were assembled using SPAdes version 3.10.0^[@CR51]^ using the "careful" mismatch mode and *k-mers* sizes of 25, 35, 45, 55, 65, 78, 85, and 95. antiSMASH 3.0 was used to predict secondary metabolic encoding gene clusters in the *A*. *oryzae* M2040 and *A*. *flavus* Afla-Guard genomes^[@CR52]^.

Phylogenetic analysis {#Sec29}
---------------------

We examined the evolutionary relationships of *A*. *oryzae* M2040, Afla-Guard, and previously sequenced isolates^[@CR26]^ using an alignment of 305,543 SNPs collected across the entire genome. SNPs were collected using the Phylogenetic and Molecular Evolution (PhaME) analysis tool on assembled genomes. All genome assemblies were performed using SPAdes version 3.10.0^[@CR51]^ as described above. The *A*. *oryzae* RIB 40 and *A*. *flavus* NRRL 3357 genomes were obtained from FungiDB^[@CR53]^. The *A*. *oryzae* RIB 40 genome was used as the reference during SNP prediction with PhaME. A phylogenetic tree was constructed using the Maximum Likelihood method based on the Hasegawa-Kishino-Yano model^[@CR54]^ with 100 bootstrap replicates in MEGA7^[@CR55]^.

AF gene cluster variation analysis {#Sec30}
----------------------------------

A number of deletions responsible for limiting AFB1 production have been previously characterized^[@CR27],[@CR56]^. We used a read depth approach to better characterize large scale deletions in the AF biosynthetic gene cluster in the *A*. *oryzae* M2040 and *A*. *flavus* Afla-Guard genomes. For all isolates, reads were mapped against the reference *A*. *flavus* NRRL 3357 genome using the "sensitive" pre-set parameters in bowtie2^[@CR57]^. SAM alignment files were converted into sorted BAM format using the view and sort functions in SAMtools^[@CR58]^. The SAMtools depth function was then used to estimate average coverage across the entire genome. Average coverage values for each non-overlapping 100 bp portion of the AF gene cluster were then divided by the average coverage across the entire genome to estimate copy number.

To further test the M2040's inability to produce AFs, the strain was cultured in submerged and solid-state media. PDB and PDA are considered the best media for optimal AFs production. One milliliter (5 × 10^7^) of *A*. *oryzae* M2040 spore suspension was inoculated into 100 ml of medium and incubated for 10 days at 30 °C with shaking at 220 rpm. For testing the AFB1 production in solid media, 0.1 ml (5 × 10^6^) of *A*. *oryzae* M2040 spore suspension was streaked on PDA plates and incubated for 7 days at 30 °C. The amount of AFB1 in the liquid and solid culture medium was analyzed by HPLC and TLC.

Identification of lineage specific genes {#Sec31}
----------------------------------------

We conservatively identified lineage specific genes in *A*. *oryzae* M2040, *A*. *flavus* Afla-Guard, *A*. *oryzae* RIB 40^[@CR22]^, and *A*. *flavus* NRRL 3357^[@CR59]^. Gene models were predicted in the *A*. *oryzae* M2040 and *A*. *flavus* Afla-Guard genome assembly using Augustus v2.5.5^[@CR60]^ with the following parameters: "strand = both", "genemodel = complete", and "species = aspergillus_oryzae". Lineage specific genes were conservatively identified in each genome by pairwise BLAST searches of each isolate's gene models against each genome^[@CR61]^. Gene models with BLAST scores \> 1e-6 were considered unique to each respective isolate. *phmmer* and *hmmscan* were used to annotate lineage specific genes^[@CR62]^.

Statistical analysis of the data {#Sec32}
--------------------------------

Statistical significance was determined using student's *t*-test with a 2-tailed distribution. Difference was considered significant as P \< 0.05. Error bars correspond to the standard deviation.
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